HBHuan Bao

Huan Bao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Huan Bao has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Bei Zhang

    Department of Neurology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200092, China

    1 shared publication
  • Can Cui

    Department of Neurology Shanghai East Hospital School of Medicine, Tongji University Shanghai China

    1 shared publication
  • Feifei Wu

    Department of Clinical Laboratory, Shanghai Gongli Hospital, The Second Military Medical University, Shanghai, China

    1 shared publication
  • Gang Li

    Department of Neurology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200092, China

    1 shared publication
  • Haifeng Ji

    Department of Neurology, Shanghai Gongli Hospital, The Second Military Medical University

    1 shared publication
  • Hao Shen

    Department of Neurology Shanghai East Hospital School of Medicine, Tongji University Shanghai China

    1 shared publication

Latest Publications

  • Association of HMOX‐1 with sporadic Alzheimer’s disease in southern Han Chinese

    by Bei Zhang, Hong‐Xiang Yu, Nan Zhi, Can Cui, Ying‐Ying Han, Min Hu, Hao Shen, Huan Bao, Gang Li

    Background and purpose: The aim of this study was to discover the associations between HMOX‐1 and Alzheimer's disease (AD).Methods: A total of 500 AD patients and 500 healthy controls were recruited in this study. Polymer chain reaction was used.Results: There was a statistically significant difference between AD patients and controls in both the dominant and recessive models of HMOX‐1 rs2071746 after adjustment for age, gender and education (dominant model: p = 0.047, odds ratio [OR] 1.34, 95% confidence interval [CI] 1.00–1.78, adjusted; recessive model: p = 0.049, OR 1.34, 95% CI 1.00–1.80, adjusted). There was also a trend for an association between the dominant model and late‐onset AD after adjustment for age, gender and education (dominant model: p = 0.084, OR 1.37, 95% CI 0.96–1.95, adjusted).Conclusions: We found an association between the dominant and recessive models of HMOX1 rs2071746 and AD.


  • Open Access

    Exosomes Derived From CircAkap7-Modified Adipose-Derived Mesenchymal Stem Cells Protect Against Cerebral Ischemic Injury

    by Limin Xu, Haifeng Ji, Yufeng Jiang, Liying Cai, Xiaoyin Lai, Feifei Wu, Rongguo Hu, Xuelian Yang, Huan Bao, Mei Jiang

    Background: Cerebral ischemic injury is a complicated pathological process. Adipose-derived stromal cells (ADSCs) have been used as a therapeutic strategy, with their therapeutic effects chiefly attributed to paracrine action rather than trans-differentiation. Studies have shown that circAkap7 was found to be downregulated in a mouse model of transient middle cerebral artery occlusion (tMCAO). Methods: To explore whether exosomes derived from circAkap7-modified ADSCs (exo-circAkap7) have therapeutic effects on cerebral ischemic injury, a mouse model of tMCAO, as well as an in vitro model of oxygen and glucose deprivation-reoxygenation (OGD-R) in primary astrocytes, were used. Results: Results showed that treatment with exo-circAkap7 protected against tMCAO in mice, and in vitro experiments confirmed that co-culture with exo-circAkap7 attenuated OGD-R-induced cellular injury by absorbing miR-155-5p, promoting ATG12-mediated autophagy, and inhibiting NRF2-mediated oxidative stress. Conclusion: We demonstrate here that exo-circAkap7 protected against cerebral ischemic injury by promoting autophagy and ameliorating oxidative stress.


  • Open Access

    Serial electromyographic findings in Guillain-Barré syndrome patients

    by Yumei Yang, Jing Lu, Huan Bao

    We sought to investigate electromyographic characteristics of Guillain-Barré syndrome (GBS) patients in the recovery phase by using serial electromyography (EMG). We included seven GBS patients and assessed their neurologic function at admission and 2, 3 and 6 months post onset using Hughes Functional Grading Scale scores. All patients underwent serial electromyographic assessment of compound muscle action potentials (CMAPs), mean conduction velocity (MCV), and distal motor latency (DML) of peripheral nerves. F wave was recorded of the median nerve and ulnar nerve. All seven patients had a Hughes Functional Grading Scale score between 3 and 6 at admission, while three patients at 2 months, one patient at 3 months, and no patient at 6 months post GBS onset had a Hughes Functional Grading Scale score between 3 and 6 (P < 0.05). No F wave was elicited in 41.7% (20/48) of the motor nerves examined at admission, which declined to 25% at 6 months post GBS onset. Decreased amplitude in CMAPs was seen in 50% (24/48) of the motor nerves examined at admission, which decreased to 25% at 6 months (P < 0.05). Moreover, 60.4% (29/48) of the motor nerves showed abnormal abduction velocity, which declined to 0% at 3 and 6 months post GBS onset (P < 0.01). In conclusion, GBS patients exhibit a variable course in recovery of electromyographic parameters, and amplitude in CMAPs cannot fully reflect recovery of muscle tone. Conduction block is reversible and in line with rapid muscle tone recovery.